Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

589 ARTÍCULOS , VIENDO DEL 316 AL 330

Statins and dementia: effect of statins beyond the treatment of dyslipidaemia

Uzokov J.

Eur J Prev Cardiol. 2022 May 5;29(5):802-803. doi: 10.1093/eurjpc/zwab226.

The Efficacy and Safety of Alzheimer's Disease Therapies: An Updated Umbrella Review

Fan F, Liu H, Shi X, Ai Y, Liu Q, Cheng Y.

J Alzheimers Dis. 2022;85(3):1195-1204. doi: 10.3233/JAD-215423.

Psychosis in Alzheimer disease - mechanisms, genetics and therapeutic opportunities

Ismail Z, Creese B, Aarsland D, Kales HC, Lyketsos CG, Sweet RA, Ballard C.

Nat Rev Neurol. 2022 Mar;18(3):131-144. doi: 10.1038/s41582-021-00597-3. Epub 2022 Jan 4.

Emotional and Neuropsychiatric Disorders Associated with Alzheimer's Disease

Heilman KM, Nadeau SE.

Neurotherapeutics. 2022 Jan;19(1):99-116. doi: 10.1007/s13311-021-01172-w. Epub 2022 Jan 10.

Methylphenidate and Other Pharmacologic Treatments for Apathy in Alzheimer's Disease

Andrade C.

J Clin Psychiatry. 2022 Feb 1;83(1):22f14398. doi: 10.4088/JCP.22f14398.

Strategic Design of Amyloid-β Species Fluorescent Probes for Alzheimer's Disease

Su D, Diao W, Li J, Pan L, Zhang X, Wu X, Mao W.

ACS Chem Neurosci. 2022 Mar 2;13(5):540-551. doi: 10.1021/acschemneuro.1c00810. Epub 2022 Feb 8.

Phage display derived peptides for Alzheimer's disease therapy and diagnosis

Zhang X, Zhang X, Gao H, Qing G.

Theranostics. 2022 Jan 31;12(5):2041-2062. doi: 10.7150/thno.68636. eCollection 2022.

The Potential Role of Gut Microbiota in Alzheimer's Disease: From Diagnosis to Treatment

Varesi A, Pierella E, Romeo M, Piccini GB, Alfano C, Bjørklund G, Oppong A, Ricevuti G, Esposito C, Chirumbolo S, Pascale A.

Nutrients. 2022 Feb 5;14(3):668. doi: 10.3390/nu14030668.

Phytochemical Compounds Loaded to Nanocarriers as Potential Therapeutic Substances for Alzheimer's Disease-Could They be Effective?

Polat DÇ, Karadağ AE, Köprülü REP, Karantas ID, Mutlu G, Çağlar EŞ, Okur ME, Okur NÜ, Siafaka PI.

Curr Pharm Des. 2022;28(30):2437-2460. doi: 10.2174/1381612828666220411104128.

A review ofimaging genetics in Alzheimer's disease

Xin Y, Sheng J, Miao M, Wang L, Yang Z, Huang H.

J Clin Neurosci. 2022 Jun;100:155-163. doi: 10.1016/j.jocn.2022.04.017. Epub 2022 Apr 26.

PET Imaging in Preclinical Anti-Aβ Drug Development

Syvänen S, Meier SR, Roshanbin S, Xiong M, Faresjö R, Gustavsson T, Bonvicini G, Schlein E, Aguilar X, Julku U, Eriksson J, Sehlin D.

Pharm Res. 2022 Jul;39(7):1481-1496. doi: 10.1007/s11095-022-03277-z. Epub 2022 May 2.

Detection and Management of Amyloid-Related Imaging Abnormalities in Patients with Alzheimer's Disease Treated with Anti-Amyloid Beta Therapy

Barakos J, Purcell D, Suhy J, Chalkias S, Burkett P, Marsica Grassi C, Castrillo-Viguera C, Rubino I, Vijverberg E.

J Prev Alzheimers Dis. 2022;9(2):211-220. doi: 10.14283/jpad.2022.21.

A Polymorphism Cluster at the 2q12 locus May Predict Response to Piromelatine in Patients with Mild Alzheimer's Disease

Schneider LS, Laudon M, Nir T, Caceres J, Ianniciello G, Capulli M, Zisapel N.

J Prev Alzheimers Dis. 2022;9(2):247-254. doi: 10.14283/jpad.2021.61.

Recent Advances Towards Diagnosis and Therapeutic Fingerprinting for Alzheimer's Disease

Pradhan LK, Sahoo PK, Chauhan S, Das SK.

J Mol Neurosci. 2022 Jun;72(6):1143-1165. doi: 10.1007/s12031-022-02009-7. Epub 2022 May 12.

Nicotinic Acetylcholine Receptors and Microglia as Therapeutic and Imaging Targets in Alzheimer's Disease

Takata K, Kimura H, Yanagisawa D, Harada K, Nishimura K, Kitamura Y, Shimohama S, Tooyama I.

Molecules. 2022 Apr 27;27(9):2780. doi: 10.3390/molecules27092780.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias